LEOCLAN Co. Ltd. (7681) AI Stock Analysis

• Market Cap: ¥6.01B
• Dividend Yield: 1.67%
• Average Volume (3M): 4.73K
• Price to Earnings (P/E): 39.3
• Beta (1Y): -0.06
• Revenue Growth: 8.51%
• EPS Growth: 12.20%
• Country: JP
• Employees: 170
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Equipment & Services
• EPS (TTM): -27.93
• Shares Outstanding: 5,922,000
• 10 Day Avg. Volume: 9,000
• 30 Day Avg. Volume: 4,726
• PEG Ratio: 0.00
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 59 Neutral
• Price Target: ¥1,162.00 ▲(14.15% Upside)

LEOCLAN Co. Ltd. has a moderate overall stock score of 59. The most significant factor is the financial performance, which is challenged by negative profitability and cash flow issues, despite a strong balance sheet. Technical analysis shows a positive trend, but valuation metrics suggest the stock is fairly valued. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Strong Balance Sheet

A strong balance sheet with no debt provides LEOCLAN with financial stability and flexibility to invest in growth opportunities without the burden of interest obligations.

Sustainability Focus

LEOCLAN's focus on sustainable and eco-friendly products aligns with global trends towards renewable energy, potentially driving long-term demand and market leadership.

Diversified Revenue Streams

Diversified revenue streams from products and services in multiple sectors reduce dependency on a single market, enhancing resilience against sector-specific downturns.

Negative Factors

Negative Profitability Margins

Negative profitability margins highlight operational challenges and inefficiencies, which could hinder LEOCLAN's ability to reinvest in growth and innovation.

Declining Revenue

Declining revenue suggests potential issues with market competitiveness or product demand, which could impact LEOCLAN's long-term growth prospects and market position.

Cash Flow Concerns

Negative cash flow from operations raises concerns about LEOCLAN's ability to sustain operations and fund growth initiatives, potentially impacting financial health.

LEOCLAN Co. Ltd. Business Overview & Revenue Model

Company Description

LEOCLAN Co.,Ltd. operates as a medical equipment trading company that meets various medical care, welfare, and health needs. It operates through three segments: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment provides incidental maintenance services; and interior decoration construction and installation works for medical institutions, preventive/health checkup facilities, nursing care/welfare facilities, etc. based on consulting services such as selection of medical equipment, as well as sells medical equipment and medical information systems. The Remote Image Diagnosis Service Business segment offers services in which diagnostic radiology specialists remotely diagnose image data taken by MRI, CT, etc., and provides information. The School Lunch Business segment provides school lunch services, including regular meals, medical meals, and other meals to nursing care and welfare facilities. LEOCLAN Co.,Ltd. was incorporated in 2001 and is headquartered in Settsu, Japan.

How the Company Makes Money

LEOCLAN Co. Ltd. generates revenue through multiple streams, primarily by selling its core products and services in the technology and renewable energy sectors. The company earns a significant portion of its income from direct sales of electronic devices and smart home systems to both consumers and businesses. Additionally, LEOCLAN has established key partnerships with major retailers and online platforms, allowing it to expand its distribution channels. The company also benefits from service contracts related to the installation and maintenance of its energy solutions, providing a recurring revenue model. Furthermore, LEOCLAN's investment in research and development enables it to innovate continuously, enhancing its product offerings and attracting new customers, thereby contributing to its overall profitability.

LEOCLAN Co. Ltd. Financial Statement Overview

Summary

LEOCLAN Co. Ltd. faces significant financial challenges, particularly in profitability and cash flow. The income statement shows declining revenues and negative profitability margins, while the cash flow statement highlights liquidity concerns. However, the balance sheet is strong, with a solid equity base and no debt, offering some financial stability.

Income Statement

LEOCLAN's income statement reveals a challenging fiscal outlook. The TTM data shows a negative EBIT and EBITDA, indicating operational inefficiencies. However, the gross profit margin remains positive at 12.63%, implying some level of cost management. Net profit margin is negative at -0.61%, highlighting profitability challenges. The company experienced a decrease in revenue over the trailing years, pointing to declining sales performance.

Balance Sheet

LEOCLAN's balance sheet is relatively strong, with a debt-free position enhancing financial stability. The equity ratio stands at a healthy 56.27%, reflecting a solid capital structure. Return on equity is negative due to the losses, but the absence of debt reduces financial risk. Overall, the company's financial health is supported by substantial equity relative to assets.

Cash Flow

The cash flow statement is concerning, with negative free cash flow and zero operating cash flow in the TTM period, indicating potential liquidity issues. The company has struggled to generate positive cash flow from operations, which is critical for sustainability. While there are no current liabilities from debt, the lack of operating cash flow raises red flags about ongoing cash management.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	21.30B	21.49B	19.80B	26.63B	29.77B	26.35B
Gross Profit	2.78B	2.74B	2.62B	2.82B	3.06B	2.73B
EBITDA	528.67M	404.56M	373.47M	536.93M	789.06M	692.94M
Net Income	263.70M	152.78M	136.06M	271.31M	437.05M	390.98M
Balance Sheet
Total Assets	11.32B	10.87B	10.66B	14.69B	13.47B	12.96B
Cash, Cash Equivalents and Short-Term Investments	5.74B	4.78B	5.57B	5.54B	5.48B	5.41B
Total Debt	87.64M	0.00	12.57M	5.67M	99.82M	127.10M
Total Liabilities	5.35B	5.05B	4.92B	8.97B	7.93B	7.81B
Stockholders Equity	5.79B	5.63B	5.57B	5.57B	5.38B	5.03B
Cash Flow
Free Cash Flow	0.00	-116.70M	-3.89M	258.41M	195.47M	1.24B
Operating Cash Flow	0.00	-86.65M	33.08M	341.56M	242.36M	1.30B
Investing Cash Flow	0.00	-619.82M	100.75M	-82.01M	-49.96M	-42.13M
Financing Cash Flow	0.00	-100.73M	-97.22M	-202.31M	-120.93M	-298.01M

LEOCLAN Co. Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1018.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7681, the sentiment is Positive. The current price of 1018 is above the 20-day moving average (MA) of 976.65, below the 50-day MA of 1041.50, and above the 200-day MA of 1016.91, indicating a neutral trend. The MACD of -4.25 indicates Negative momentum. The RSI at 55.54 is Neutral, neither overbought nor oversold. The STOCH value of 36.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7681.

LEOCLAN Co. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7634	78 Outperform	¥15.31B	10.57	―	1.61%	0.59%	3.90%
2796	60 Neutral	¥6.21B	-23.75	―	2.65%	15.66%	56.93%
7681	59 Neutral	¥6.01B	39.26	―	1.67%	8.51%	12.20%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
3750	45 Neutral	¥7.39B	-4.01	―	―	-93.79%	-1332.86%
3628	40 Underperform	¥6.32B	-2.35	―	―	-4.07%	-88.89%